Abstract:Our aim was to construct the eukaryotic expressional system of single-chain antibody (ScFv(2F9)) derived from a new clone of monoclonal antibody named ZCH-7-2F9 against human CD14 antigen, and to obtain the ScFv(2F9) protein with a high biological activity for further studies on ScFv(2F9) immunotoxin and other kinds of genetically engineered antibodies. Primers were synthesized according to the gene sequence of ScFv(2F9), 4 tandem glysines and 1 serine (Gly4Ser)3 linker and multiple cloning site(MCS) of pSectag2A vector, which included SfiI and EcoRI enzyme cleaving site, 6 x His and stop code TGA sequences. ScFv(2F9) gene was amplified through splicing by overlap extension (SOE) using the high fidelity Taq polymerase. Then the gene was cloned to pGEM-T easy and pSectag2A vectors. Positive recombinants (pSectag2A/ScFv(2F9)) were identified through enzyme cleaving and sequenced before expression. The recombinant plasmids were transfected into Chinese hamster ovary (CHO) cells for expression. The relative molecular weight (MW) and the binding activity of the interesting protein were determined by SDS-PAGE, Western-blot and flow cytometry (FCM), respectively. The scFv(2F9) V-H is a member of the IgH gene family V, subgroup and the scFv(2F9) V-L gene belongs to the Ig(k) gene family V-10 subgroup. The recombined ScFv(2F9) gene was identified to be functional by sequencing and expressing. The interesting protein could be detected in the culture supernatant of transformed CHO cells with a MW of 31 kDa. The blocking test showed that the positive cell percentages, the mean fluorescence intensity (MFI) and the peak of channel (peak Ch) were reduced by 90.02%, 63.3% and 63.38%, respectively after blockage of ScFv(2F9). The ScFv(2F9) gene was cloned and the interest protein against human CD14 antigen has been successfully expressed in eukaryotic cells with a high biological activity, which lays the foundation for further studies on its immunotoxin and other kinds of engineered antibodies.

Soluble expression, purification and bioactivity assay of anti-ovarian carcinoma×anti-CD3×anti-CD28VH single chain trispecific antibody

Construction and Expression of a Single-Chain Bispecific Antibody COC183B2/anti-CD3 Against Human Ovarian Carcinoma

Anti-tumor Effect and Its Antigenic Specificity of Cytotoxicity T Lymphocytes Induced by SKOV3 Ovarian Carcinoma Cell Line Freeze-thaw Antigen

Some Characteristics and Purification of Anti-(Human Ovarian Carcinoma) X Anti-(Human Cd3) Single-Chain Bispecific Antibody

Cloning, Purification and Bioactivity Assay of Human CD28 Single-Chain Antibody in Escherichia Coli

Construction and Expression of Single-Chain Antibody Derived from a New Clone of Monoclonal Antibody Against Human CD14 in CHO Cells

High Level Expression of 3D5 Ovarian Carcinoma Anti-idiotypic Single-Chain Antibody (3D5ScFv) in E.coli

Expression and Purification of HPV58 E1 Protein and Preparation of Polyclonal Antibodies against HPV 58 E1 Protein

Fusion of Chemotactic Peptide to A Single-Chain Bi-Specific Antibody (scbsab) Potentiates Its Cytotoxicity to Target Tumour Cells

Soluble Expression and Purification of a Novel Single-Chain Fv Antibody Against Connective Tissue Growth Factor(ctgf/ccn2)

Construction,expression,and Identification of Ovarian Anti-Idiotypic Single Chain Antibody 6b11scfv and Mouse HSP70 Fusion Protein

THE STUDY OF EXPRESSION AND FUNCTION OF ANTIBODY-CYTOKINE FUSION PROTEIN 183B2scfv-Interleukin 2

Effect of OSMcAb-HSA-MTX conjugate on human osteosarcoma

Optimized Expression, Purity and Identification of Single- Chain Fv Antibody Against Hepatocellular Carcinoma

Humanization of Ovarian Carcinoma Anti-idiotype Single-chain (V_L-V_H-CH3) Antibody

Preparation and characterization of monoclonal antibody against hTSC29 pep-tides

Environmental Stimuli on the Soluble Expression of Anti-Human Ovarian Carcinoma × Anti-Human CD3 Single-Chain Bispecific Antibody in Recombinant Escherichia Coli

Development of an Anti-HER2 Single-Chain Variable Antibody Fragment Construct for High-Yield Soluble Expression in Escherichia coli and One-Step Chromatographic Purification

The preparation of VEGFR1/CD3 bispecific antibody and its specific cytotoxicity against VEGFR1-positive breast cancer cells.

Preparation and Identification of Monoclonal Antibody Against Tumor-Associated Antigen OVA66

ESTABLISHMENT OF HYBRIDOMA CELL LINES SECRETING ANTI-TERBUTALINE MONOCLONAL ANTIBODY AND PREPARATION, IDENTIFICATION OF ITS IMMUNOLOGICAL PROPERTIES